首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Cloning of apoB intrabodies: specific knockdown of apoB in HepG2 cells
Authors:Liao Wei  Strube Randall W  Milne Ross W  Chen Si-Yi  Chan Lawrence
Institution:a Department of Medicine and Molecular & Cellular Biology, Baylor College of Medicine, St. Luke’s Episcopal Hospital, Houston, TX, USA
b Department of Molecular & Human Genetics and Center for Gene Therapy, Baylor College of Medicine, Houston, TX, USA
c Department of Pathology and Laboratory Medicine, University of Ottawa Heart Institute, Ottawa, Ont., Canada
d St. Luke’s Episcopal Hospital, Houston, TX, USA
Abstract:Apolipoprotein (apo) B is essential for the assembly and secretion of triglyceride-rich lipoproteins made by the liver. As the sole protein component in LDL, apoB is an important determinant of atherosclerosis susceptibility and a potential pharmaceutical target. Single-chain antibodies (sFvs) are the smallest fragment of an IgG molecule capable of maintaining the antigen binding specificity of the parental antibody. In the present study, we describe the cloning and construction of two intracellular antibodies (intrabodies) to human apoB. We targeted these intrabodies to the endoplasmic reticulum for the purpose of retaining nascent apoB within the ER, thereby preventing its secretion. Expression of the 1D1 intrabody in the apoB-secreting human hepatoma cell line HepG2 resulted in marked reduction of apoB secretion. This study demonstrates the utility of an intrabody to specifically block the secretion of a protein determinant of plasma LDL as a therapeutic strategy for the treatment of hyperlipidemia.
Keywords:Apo  apolipoprotein  ER  endoplasmic reticulum  ALLN  l-leucinyl-l-leucinyl-l-norleucinal" target="_blank">N-acetyl-l-leucinyl-l-leucinyl-l-norleucinal  NEM  N-ethylmaleimide  PAGE  polyacrylamide gel electrophoresis  sFvs  single-chain antibodies
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号